AAAAAA

   
Results: 1-12 |
Results: 12
Symbolic description of intracerebral vessels segmented from magnetic resonance angiograms and evaluation by comparison with X-ray angiograms
Authors: Bullitt, E Aylward, S Smith, K Mukherji, S Jiroutek, M Muller, K
Citation: E. Bullitt et al., Symbolic description of intracerebral vessels segmented from magnetic resonance angiograms and evaluation by comparison with X-ray angiograms, MED IMAGE A, 5(2), 2001, pp. 157-169
Combined etoposide, ifosfamide, and cisplatin in the treatment of patientswith advanced thymoma and thymic carcinoma - An intergroup trial
Authors: Loehrer, PJ Jiroutek, M Aisner, S Aisner, J Green, M Thomas, CR Livingston, R Johnson, DH
Citation: Pj. Loehrer et al., Combined etoposide, ifosfamide, and cisplatin in the treatment of patientswith advanced thymoma and thymic carcinoma - An intergroup trial, CANCER, 91(11), 2001, pp. 2010-2015
Comparison of survival and quality of life in advanced non-small-cell lungcancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperativeoncology group trial
Authors: Bonomi, P Kim, KM Fairclough, D Cella, D Kugler, J Rowinsky, E Jiroutek, M Johnson, D
Citation: P. Bonomi et al., Comparison of survival and quality of life in advanced non-small-cell lungcancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an eastern cooperativeoncology group trial, J CL ONCOL, 18(3), 2000, pp. 623-631
Predictors of high yield and purity of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma
Authors: Webb, IJ Schlossman, RL Jiroutek, M Doss, D Cohen, CA Freeman, A Schott, DM Anderson, KC
Citation: Ij. Webb et al., Predictors of high yield and purity of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma, CYTOTHERAPY, 1(3), 1999, pp. 175-182
Distribution of carcinoma in radical prostatectomy specimens in the era ofserum prostate-specific antigen testing - Implications for delivery of localized therapy
Authors: Vargas, SO Jiroutek, M D'Amico, AV Renshaw, AA
Citation: So. Vargas et al., Distribution of carcinoma in radical prostatectomy specimens in the era ofserum prostate-specific antigen testing - Implications for delivery of localized therapy, AM J CLIN P, 112(3), 1999, pp. 373-376
Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens - Validation in a cohort of 434 patients
Authors: Renshaw, AA Richie, JP Loughlin, KR Jiroutek, M Chung, A D'Amico, AV
Citation: Aa. Renshaw et al., Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens - Validation in a cohort of 434 patients, AM J CLIN P, 111(5), 1999, pp. 641-644
Performance characteristics of rapid (30-second) prescreening - Implications for calculating the false-negative rate and comparison with other quality assurance techniques
Authors: Renshaw, AA Cronin, JA Minter, LJ Nappi, D Whitman, T Jiroutek, M Cibas, ES
Citation: Aa. Renshaw et al., Performance characteristics of rapid (30-second) prescreening - Implications for calculating the false-negative rate and comparison with other quality assurance techniques, AM J CLIN P, 111(4), 1999, pp. 517-522
Perineural invasion in prostate needle biopsy specimens - Correlation withextraprostatic extension at resection
Authors: Vargas, SO Jiroutek, M Welch, WR Nucci, MR D'Amico, AV Renshaw, AA
Citation: So. Vargas et al., Perineural invasion in prostate needle biopsy specimens - Correlation withextraprostatic extension at resection, AM J CLIN P, 111(2), 1999, pp. 223-228
Accuracy and reproducibility of estimating the adequacy of the squamous component of cervicovaginal smears
Authors: Renshaw, AA Friedman, MM Rahemtulla, A Granter, SR Dean, BR Cronin, JA Jiroutek, M Cibas, ES
Citation: Aa. Renshaw et al., Accuracy and reproducibility of estimating the adequacy of the squamous component of cervicovaginal smears, AM J CLIN P, 111(1), 1999, pp. 38-42
Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin
Authors: Rowinsky, EK Jiroutek, M Bonomi, P Johnson, D Baker, SD
Citation: Ek. Rowinsky et al., Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin, CLIN CANC R, 5(4), 1999, pp. 767-774
Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?
Authors: D'Amico, AV Davis, A Vargas, SO Renshaw, AA Jiroutek, M Richie, JP
Citation: Av. D'Amico et al., Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?, INT J RAD O, 43(3), 1999, pp. 587-590
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens - Reply
Authors: Renshaw, A Jiroutek, M
Citation: A. Renshaw et M. Jiroutek, The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens - Reply, CANCER, 85(5), 1999, pp. 1209-1210
Risultati: 1-12 |